Literature DB >> 24775805

Composite outcomes in coronary bypass surgery versus percutaneous intervention.

Fred H Edwards1, David M Shahian2, Maria V Grau-Sepulveda3, Frederick L Grover4, John E Mayer5, Sean M O'Brien3, Elizabeth DeLong3, Eric D Peterson3, Charles McKay6, Richard E Shaw7, Kirk N Garratt8, George D Dangas9, John Messenger4, Lloyd W Klein10, Jeffrey J Popma11, William S Weintraub12.   

Abstract

BACKGROUND: Recent observational studies show that patients with multivessel coronary disease have a long-term survival advantage with coronary artery bypass grafting (CABG) compared with percutaneous coronary intervention (PCI). Important nonfatal outcomes may also affect optimal treatment recommendation.
METHODS: CABG was compared with percutaneous catheter intervention by using a composite of death, myocardial infarction (MI), or stroke. Medicare patients undergoing revascularization for stable multivessel coronary disease from 2004 through 2008 were identified in national registries. Short-term clinical information from the registries was linked to Medicare data to obtain long-term follow-up out to 4 years from the time of the procedure. Propensity scoring with inverse probability weighting was used to adjust for baseline risk factors.
RESULTS: There were 86,244 CABG and 103,549 PCI patients. The mean age was 74 years, with a median 2.67 years of follow-up. At 4 years, the propensity-adjusted adjusted cumulative incidence of MI was 3.2% in CABG compared with 6.6% in PCI (risk ratio, 0.49; 95% confidence interval, 0.45 to 0.53). At 4 years, the cumulative incidence of stroke was 4.5% in CABG compared with 3.1% in PCI patients (risk ratio, 1.43; 95% confidence interval, 1.31 to 1.54). This difference was primarily due to the higher 30-day stroke rate for CABG (1.55% vs 0.37%). For the composite of death, MI, or stroke, the 4-year adjusted cumulative incidence was 21.6% for CABG and 26.7% for PCI (risk ratio, 0.81; 95% confidence interval, 0.78 to 0.83).
CONCLUSIONS: The 4-year composite event rate of death, MI, and stroke favored CABG, whereas the risk of stroke alone favored PCI.
Copyright © 2014 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24775805      PMCID: PMC4104475          DOI: 10.1016/j.athoracsur.2014.01.087

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  29 in total

1.  Adjusted survival curves with inverse probability weights.

Authors:  Stephen R Cole; Miguel A Hernán
Journal:  Comput Methods Programs Biomed       Date:  2004-07       Impact factor: 5.428

2.  Late outcome after stenting or coronary artery bypass surgery for the treatment of multivessel disease: a single-center matched-propensity controlled cohort study.

Authors:  Ron T van Domburg; Johanna J M Takkenberg; Leo J Noordzij; Francesco Saia; Lex A van Herwerden; Patrick W J C Serruys; Ad J J C Bogers
Journal:  Ann Thorac Surg       Date:  2005-05       Impact factor: 4.330

3.  Long-term outcomes of coronary-artery bypass grafting versus stent implantation.

Authors:  Edward L Hannan; Michael J Racz; Gary Walford; Robert H Jones; Thomas J Ryan; Edward Bennett; Alfred T Culliford; O Wayne Isom; Jeffrey P Gold; Eric A Rose
Journal:  N Engl J Med       Date:  2005-05-26       Impact factor: 91.245

4.  Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging.

Authors:  Joseph B Selvanayagam; Italo Porto; Keith Channon; Steffen E Petersen; Jane M Francis; Stefan Neubauer; Adrian P Banning
Journal:  Circulation       Date:  2005-02-21       Impact factor: 29.690

5.  Cognitive function 5 years after randomization to coronary angioplasty or coronary artery bypass graft surgery.

Authors:  M A Hlatky; C Bacon; D Boothroyd; E Mahanna; J G Reves; M F Newman; I Johnstone; C Winston; M M Brooks; A D Rosen; D B Mark; B Pitt; W Rogers; T Ryan; R Wiens; J A Blumenthal
Journal:  Circulation       Date:  1997-11-04       Impact factor: 29.690

6.  Neuropsychological outcome after percutaneous coronary intervention or coronary artery bypass grafting: results from the Stent or Surgery (SoS) Trial.

Authors:  Peter Währborg; Jean E Booth; Tim Clayton; Fiona Nugara; John Pepper; William S Weintraub; Ulrich Sigwart; Rod H Stables
Journal:  Circulation       Date:  2004-11-22       Impact factor: 29.690

7.  Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features.

Authors:  Sorin J Brener; Bruce W Lytle; Ivan P Casserly; Jakob P Schneider; Eric J Topol; Michael S Lauer
Journal:  Circulation       Date:  2004-04-26       Impact factor: 29.690

8.  Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease.

Authors:  Edward L Hannan; Chuntao Wu; Gary Walford; Alfred T Culliford; Jeffrey P Gold; Craig R Smith; Robert S D Higgins; Russell E Carlson; Robert H Jones
Journal:  N Engl J Med       Date:  2008-01-24       Impact factor: 91.245

9.  Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.

Authors:  Patrick W Serruys; Marie-Claude Morice; A Pieter Kappetein; Antonio Colombo; David R Holmes; Michael J Mack; Elisabeth Ståhle; Ted E Feldman; Marcel van den Brand; Eric J Bass; Nic Van Dyck; Katrin Leadley; Keith D Dawkins; Friedrich W Mohr
Journal:  N Engl J Med       Date:  2009-02-18       Impact factor: 91.245

10.  Comparison of coronary artery stenting outcomes in the eras before and after the introduction of drug-eluting stents.

Authors:  Edward L Hannan; Michael Racz; David R Holmes; Gary Walford; Samin Sharma; Stanley Katz; Robert H Jones; Spencer B King
Journal:  Circulation       Date:  2008-04-07       Impact factor: 29.690

View more
  3 in total

Review 1.  Should Chronic Total Occlusion Be Treated With Coronary Artery Bypass Grafting? Chronic Total Occlusion Should Not Routinely Be Treated With Coronary Artery Bypass Grafting.

Authors:  William S Weintraub; Kirk N Garratt
Journal:  Circulation       Date:  2016-05-03       Impact factor: 29.690

2.  Clinical Trials Versus Clinical Practice: When Evidence and Practice Diverge--Should Nondiabetic Patients With 3-Vessel Disease and Stable Ischemic Heart Disease Be Preferentially Treated With CABG?

Authors:  Pranav Kansara; Sandra Weiss; William S Weintraub; Matthew C Hann; James Tcheng; S Tanveer Rab; Lloyd W Klein
Journal:  JACC Cardiovasc Interv       Date:  2015-11       Impact factor: 11.195

3.  Interim monitoring of nonrandomized prospective studies that invoke propensity scoring for decision making.

Authors:  Stacia M DeSantis; Michael D Swartz; Thomas J Greene; Erin E Fox; John B Holcomb; Charles E Wade
Journal:  J Trauma Acute Care Surg       Date:  2020-02       Impact factor: 3.697

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.